Thymidine phosphorylase levels as a prognostic factor in renal cell carcinoma

BJU International

Volumn 91, Issue 1, 2003, Pages 105-108

  Wada, S ^a   Yoshimura, R ^a   Naganuma, T ^a   Yoshida, N ^a   Narita, K ^a   Ikemoto, S ^a  

^a OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Grade; Prognostic factor; Renal cell carcinoma; Thymidine phosphorylase

Indexed keywords

GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CELL TYPE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NEPHROTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; ENZYME IMMUNOASSAY; HISTOLOGY; KIDNEY PARENCHYMA; NEPHRECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; THYMIDINE PHOSPHORYLASE;

EID: 0037234720     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.03050.x     Document Type: Article

References (23)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82: 4-6
2. O'Brien TS, Fox SB, Dickenson AJet al. Expression of angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancer. Cancer Res 1996;56: 4799-804
3. Miyazono K, Okabe T, Urabe Aet al. Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 1987;262: 4098-103
4. Ishikawa F, Miyazono K, Hellman U et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial growth factor. Nature 1989;338: 557-62
5. Furukawa T, Yoshimura A, Sumizawa T et al. Angiogenic factor. Nature 1992; 356: 668
6. Reynolds K, Farzaneh F, Collins WPet al. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 1994;86: 1234-8
7. Takebayashi Y, Yamada K, Miyadera Ket al. The expression and activity of thymidine phosphorylase in human solid tumors. Eur J Cancer 1996;32: 1227-32
8. Blath RA, Mancilla-Jimenez R, Stanley RJ. Clinical comparison between vascular and avascular renal cell carcinoma. J Urol 1976;115: 514-9
9. Hermanek P, Sobin LH eds.UICC TNM Classification of Malignant Tumors, 4th Edn. 2nd Revision, Berlin: Springer-Verlag, 1992
10. Kern WF, Laszik ZG, Nadasdy T, Silva FG, Bane BL, Pitha JV edsAtlas of Renal Pathology. 1st Edn. Chapt 23. Philadelphia: WB Saunders, 1998: 275-308
11. Imazono Y, Takebayashi Y, Nishiyama Ket al. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 1997;15: 2570-8
12. Nishida M, Hino A, Mori Ket al. Preparation of anti-human thymidine phosphorylase monoclonal antibody useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 1996;19: 1407-11
13. Lowry OH, Rosebrough NJ, Farr ALet al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193: 265-75
14. Eda H, Fujimoto K, Watanabe Set al. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 1993;32: 333-8
15. Van Brussel JP, Mickisch GHJ. Prognostic factors in renal cell carcinoma and bladder cancer. BJU Int 1999;83: 902-9
16. Brethean D, Lechevallier E, de Fromont M et al. Prognostic value of nuclear grade of renal cell carcinoma. Cancer 1994;76: 2543-9
17. Yasunaga Y, Shin M, Miki Tet al. Prognostic factors of renal cell carcinoma: A multivariate analysis. J Surg Oncol 1998; 68: 11-8
18. Delahunt B, Nacey JN. Renal cell carcinoma II. Histologic indicators of prognosis. Pathology 1987;19: 258-63
19. Jacobsen J, Rasmuson T, Grankvist Ket al. Vascular endothelial growth factors as prognostic factor in renal cell carcinoma. J Urol 2000;163: 343-7
20. Skinner DG, Colvin RB, Vermillion CDet al. Diagnosis and management of renal cell carcinoma: A clinical and pathologic study of 309 cases. Cancer 1971;28: 1165-77
21. Onodera Y, Matsuda N, Ohta Met al. Prognostic significance of tumor grade for renal cell carcinoma. Int J Urol 2000;7: 4-9
22. Amin MB, Amin MB, Tamboli Pet al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases. Am J Surg Pathol 2002;26: 281-91
23. Lau WK, Cheville JC, Blute MLet al. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Urology 2002;59: 532-7